Síndrome de Schöenlein-Henoch

Revista Espanola de Reumatologia

Volumn 27, Issue 2, 2000, Pages 54-65

  Blanco, Ricardo ^a   Rodríguez Valverde, Vicente ^a   Mata Arnaiz, Cristina ^a   Martínez Taboada, Víctor M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006012275     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. a ed.). Filadelfia: W.B. Saunders Company, 1995; 365-422.
2. White RHR. Henoch-Schönlein Purpura. En: Churg A, Churg J, editores. Systemic vasculides. Nueva York: Igaku-Shoin, 1992; 203-17.
3. Lie JT, and the Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990; 33: 1.074-87.
4. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 1978; 89: 660-76.
5. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990; 33: 1.065-67.
6. Bloch DA, Michel BA, Hunder GG, Meschane DJ, Arend WP, Calabrese LH et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and Methods. Arthritis Rheum 1990; 33: 1.068-73.
7. Michel BA, Hunder GG, Bloch DA, Calabrese LH. Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the two disorders. J Rheumatol 1992; 19: 721-28.
8. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1.114-21.
9. Jennette JC, Falk RP, Andrassy K, Bacon PA, Churg J, Gross WL et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
10. Hené RJ, Velthuis P, Van de Wiel A, Klepper D, Mees EJD, Kater L. The relevance of IgA Deposits in Vessel walls of clinically Normal Skin. Arch Intern Med 1986; 146: 745-49.
11. Helander SD, De Castro FR, Gibson LE. Henoch-Schönlein Purpura: Clinicopathologic correlation of cutaneous vascular IgA Deposits and the relationship to leukocytoclastic vasculitis. Acta Derm Venereol (Stockh) 1995; 75: 125-29.
12. Lie JT. Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum 1994; 37: 181-86.
13. Rodríguez-Valverde V, Blanco R, Martínez-Taboada VM. Henoch-Schönlein purpura in adulthood and in childhood (in reply). Arthritis Rheum 1998; 41: 1.518-20.
14. Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M, González-Gay MA. Henoch-Schönlein purpura in adulthood and in childhood: two different expressions of the same syndrome. Arthritis Rheum 1997; 40: 859-64.
15. Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine (Baltimore) 1998; 77: 403-18.
16. Farley TA, Guillespie S, Rasoulpour M et al. Epidemiology of a cluster of Henoch-Schönlein purpura. Am J Dis Child 1989; 143: 798.
17. Steward M, Savage JM, Bell B et al. Long term renal prognosis and Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 1988; 147: 113.
18. Watts RA, Carruthers DM, Scott DG. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995; 25: 28-34.
19. Blanco R, González-Gay MA, Ibáñez D, López-Viana A, Ferrán C, Regueira et al. Henoch-Schönlein Purpura as clinical presentation of a myelodysplasic syndrome. Clin Rheumatol 1997; 16: 626-28.
20. Blanco R, González-Gay MA, Ibáǹez D, Alba C, Pérez de Llano LA. Henoch-Schönlein Purpura as clinical presentation of a small-cell lung cancer. Clin Exp Rheumatol 1997; 15: 545-47.
21. Kurzrock R, Cohen P, Markowitz. Clinical manifestations of vasculitis in patients with solid tumors. Arch Intern Med 1994; 154: 334-40.
22. Casanueva B, Rodríguez-Valverde V, Fariñas MC, Vallo A, Rodrïguez-Soriano J. Autologous mixed lymphocyte reaction and T-cell suppressor activity in patients with Henoch-Schönlein purpura and IgA nephropathy. Kephron 1990; 54: 224-28.
23. Casanueva B, Rodríguez-Valverde V, Luceño A; Circulating IgA producing cells in the differencial diagnosis of Henoch-Schönlein purpura. J Rheumatol 1988; 15: 1.229-33.
24. Saulsbury FT. Heavy and light chain composition of serum IgA rheumatoid factor in Henoch-Schonlein purpura. Arthritis Rheum 1992; 35: 1.377-80.
25. Saulsbury FT. Increased serum IgD concentrations in childrenwith Henoch-Schönlein purpura. Br J Rheumatol 1998; 37: 570-72.
26. Kawana S, Nishiyama S. Serum C5b- 9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schonlein purpura. Dermatology 1992, 184; 171-76.
27. Abou-Ragheb HHA, Williams AJ, Brown CB, Milford-Ward A. Plasma Levels of the Anaphylatoxins C3a and C4a in patients with IgA Nephropathy/Menoch-Schonlein nephritis. Nephron 1992; 62: 22-6.
28. Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A et al. The role of cytokines in Henoch Schonlein purpura. Scand J Rheumatol 1997; 26: 456-60.
29. De Mattia D, Penza R, Giordano P, Del Vecchio GC, Aceto G, Altomare M et al. Von Willerand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol 1995; 5: 603-5.
30. Fukui H, Kamitsuji H, Nagao T. Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Thromb Res 1989; 56: 667-75.
31. Tonshoff B, Momper R, Schweer H, Scharer K, Seyberth HW. Increased biosynthesis of vasoactive prostanoids in Schonlein-Henoch purpura. Pediatr Res 1992; 32: 137-40.
32. Jennette JC, Wieslander J, Tuttle R, Falk RJ. Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. Am J Kidney Dis 1991; 18: 466-71.
33. O'Donoghue DJ, Darvill A, Ballardie FW. Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura. J Clin Invest 1991; 88: 1.522-30.
34. O'Donoghue DJ, Jewkes F, Posllehwiute RJ, Ballardie FW. Autoimmunity to Glomerular Antigens in Henoch-Schönlein Nephritis. Clin Sci 1992; 83: 281-87.
35. Wananukul S, Pongprasit P, Korkij W. Henoch-Schonlein purpura presenting as hemorrhagic vesicles and bullae: case report and literature review. Pediatr Dermatol 1995; 4: 314-17.
36. Katos, Shibuya H, Kaganuma H, Nakahawa H. Gastrointestinal endoscopy in Henoch-Schönlein purpura. Eur J Pediatr 1992; 151: 482-84.
37. Cappel MS, Gupta AM. Colonic lesions associated with Henoch-Schönlein purpura. Am J Gastroenterol 1990; 85: 1.186-88.
38. Couture A, Veyrac C, Baud C, Galifer RB, Armelin I. Evaluation of abdominal pain in Henoch-Schönlein syndrome by high frequency ultrasound. Pediatr Radiol 1992; 22: 12-7.
39. Connolly B, O'Halpin D. Sonographic evaluation of the abdomen in Henoch-Schönlein purpura. Clin Radiol 1994; 49: 320-23.
40. Santiago J, Blanco R, González-Gay MA, Mateos A, Rosés L, Sánchez-Andrade A et al. Henoch-Schönlein purpura with hemorrhagic ascites and intestinal serositis. Gastrointest Endosc 1996; 44: 624-25.
41. Goldstein AR, White RHR, Akuse R, Chandler C. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992; 339: 280-82.
42. Chaussain M, De Boissieu D, Kalifa G, Epelbaum S, Niaudet P, Badoual J et al. Impairment of lung diffusion capacity in Henoch-Schönlein purpura. J Pediatr 1992; 121: 12-6.
43. Eichenfield LF, Wright WK. Pulmonary hemorrhage associated with Henoch-Schonlein purpura [carta]. Pediatr Dermatol 1998; 15: 143.
44. Chamberlain RS, Greenberg LW. Scrotal involvement in Henoch-Schönlein purpura: a case report and review of the literature. Pediatr Emerg Care 1992; 8: 213-15.
45. Singer JI, Kisson N, Gloor J. Acute testicular pain: Henoch-Schönlein purpura versus testicular torsion. Pediatr Emerg Care 1992; 8: 51-3.
46. Maherzi A, Kaabar N, Boussetta K, Salem M, Hammou A, Chaouachi B et al. Bilateral stenosing ureteritis in Henoch-Schonlein purpura. Arch Pediatr 1997; 4: 36-9.
47. Belman AL, Leicher CR, Moshe SL, Mezey AP. Neurologic manifestations of Schonlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 1985; 75: 687-92.
48. Roth R, Wilz DR, Theil GB. Schönlein-Henoch syndrome in adults. Q J Med 1985; 55: 145-59.
49. Lee HS, Koh HI, Kim MJ, Rha HY. Henoch-Schöenlein nephritis in adults: a clinical and morphological study. Clin Nephrol 1986; 26: 125-30.
50. Fogazzi GB, Pasquali S, Moriggi M, Casanova S, Damilano I, Mihatsch MJ et al. Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol 1989; 31: 60-6.
51. Cream JJ, Gample JM, Peachey RDG. Schönlein-Henoch purpura in the adult. Q J Med 1970; 39: 461-82.
52. Allen DM, Diamong LK, Howell DA. Anaphylactoid purpura in children. Am J Dis Child 1960; 99: 147-68.
53. Legrain V, Lejean S, Taïeb A, Guillard JM, Battin J, Maleville J. Infantile acute hemorrhagic edema of the skin: study of ten cases. J Am Acad Dermatol 1991; 24: 17-22.
54. Kondo N, Kasahara K, Shinoda S, Orii T. Accelerated expression of secreted alpha chain gene in anaphylatoid purpura. J Clin Immunol 1992; 12: 193-96.
55. García Fuentes M, Chantler C, Williams DG. Cryoglobulinaemia in Henoch-Schönlein purpura. BMJ 1977; 2: 163-65.
56. Van den Wall Bake A, Lobatto S, Jonges L. IgA antibodies directed against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schönlein purpura. Adv Exp Med Biol 1987; 216: 1.593-98.
57. Shaw G, Ronda N, Bevan JS, Esnault V, Griffiths DFR, Rees A. Antineutrophil cytoplasmic antibodies (ANCA) of IgA class correlate with disease activity in adult Henoch-Schönlein purpura. Nephrol Dial Transplant 1992; 7: 1.238-41.
58. O'Donogue DJ, Nusbaum P, Noel LH, Halbwachs-Mecarelli L, Lesavre PH. Antineutrophil cytophasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura. Nephrol Dial Transplant 1992; 7: 534-38.
59. Guillevein L, Lhote F. Distinguising polyarteritis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol 1995; 7: 20-4.
60. Martínez-Taboada VM, Blanco R, Rodríguez-Valverde V. Hypersensitivity vasculitis. Lancet 1997; 350: 1.036.
61. Martínez-Taboada VM, Blanco R, Garcia-Fuentes M, Rodríguez-Valverde V. Clinical features and outcome of 95 patiens with hypersensitivity vasculitis. Am J Med 1997; 2: 186-91.
62. Niaudet P, Murcia I, Beaufils H, Broyer M, Habib R. Primary IgA nephropathies in children: prognosis and treatment. Adv Nephol Necker Hosp 1993; 2: 121-40.
63. Hasegawa A, Kawamura T, Ito H, Hasegawa O et al. Fate of renal grafts with recurrent Henoch-Schönlein purpura nephritis in children. Transplant Proc 1989; 21: 2.130-33.
64. Nyberg G, Akesson P, Nordén G, Wieslander J. Systemic vasculitis in a kidney transplant population. Transplantation 1997; 63: 1.273-77.
65. Haubitz M, Kliem V, Koch KM, Nashan H, Schlitt HJ, Pichlmayer R et al. Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. Transplantation 1997; 63: 1.251-57.
66. Callen JP, Spencer LV, Barruss JB. Holtman J. Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 1991; 127: 515-22.
67. Lee YJ, Horstman LL, Ahn YS. Danazol for Henoch-Schönlein purpura Ann Intern Med 1993; 118: 827.
68. Turner AN, Whittaker S, Banks I, Jones KK, Pussey CD. Plasma exchange in refractory cutaneous vasculitis. Br J Dermatol 1990; 122: 411-15.
69. Rosemblum ND, Winter HS. Steroid Effects on the course of abdominal pain in Henoch-Schönlein purpura. Pediatrics 1987; 79: 1.018-21.
70. Glasier CM, Siegel MJ, McAlister WH, Shackerlford GD. Henoch-Schönlein syndrome in children: gastrointestinal manifestations. Am J Roentgenol 1981; 136: 1.081-85.
71. Buchanec J, Galanda V, Belakova S, Minarik M, Zibolen M. Incidence of renal complications in Henoch-Schönlein Purpura syndrome in depende of an early administration of steroids. Int Urol Nephrol 1988; 20: 409-12.
72. Mollica F, Li Volti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992; 151: 140-44.
73. Saulsbury F. Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 1993; 7: 69-71.
74. Hurley RM, Drummond KN. Anaphylactoid purpura nephritis: clinicopathological correlations. J Pediatr 1972; 91: 904-11.
75. Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH et al. Prognosis of Henoch-Schönlein nephritis in children. Br Med J 1977; 2: 7.
76. Nowack R, Birck R, Van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 1997; 349: 774.
77. Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 1995; 9: 6-10.
78. Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L et al. High-dose immunoglobulin therapy for severe IgAnephropathy and Henoch-Schönlein purpura. Ann Intern Med 1991; 120: 476-81.
79. Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L et al. Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Nephron 1995; 69: 327-34.
80. Schifferli J, Leski M, Favre H, Imbach P, Nydegger U, Davies K. High-dose intravenous IgG treatment and renal function. Lancet 1991; 337: 457-58.
81. Pasatiempo AMG, Kroser JA, Rudnick M, Hoffman BI. Acute renal failure after intravenous immunoglobulin therapy. J Rheumatol 1994; 21: 347-58.
82. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992; 326: 107-16.
83. Blanco R, González-Gay MA, Ibáñez D, Sánchez-Andrade A, Gonzalez-Vela C. Paradoxical and persistent renal impairment in Henoch-Schönlein Purpura after high-dose immunoglobulin therapy. Nephron 1997; 76: 247-48.